These effects increased in ANXA2-silenced GBM cells, which displayed a significant reduction of Nestin+ and CD133+ cells instead of Sox2 (Figure 7F–7J and Supplementary Figure S9D, S9E). The gene discussed is ANXA2; the disease is glioblastoma.